Cargando…
Plasma versican and plasma exosomal versican as potential diagnostic markers for non-small cell lung cancer
BACKGROUND AND AIMS: This study aimed to investigate the expression of plasma versican and plasma exosomal versican in non-small cell lung cancer (NSCLC) and its correlation with clinicopathological features, and to evaluate its diagnostic performance in NSCLC and its predictive function for NSCLC i...
Autores principales: | Chang, Wenjing, Zhu, Jichao, Yang, Dianyu, Shang, Anquan, Sun, Zujun, Quan, Wenqiang, Li, Dong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10230736/ https://www.ncbi.nlm.nih.gov/pubmed/37259101 http://dx.doi.org/10.1186/s12931-023-02423-4 |
Ejemplares similares
-
Inflammation Amplification by Versican: The First Mediator
por: Zhang, Zhenwei, et al.
Publicado: (2012) -
Versican in inflammation and tissue remodeling: The impact on lung disorders
por: Andersson-Sjöland, Annika, et al.
Publicado: (2015) -
Versican Expression during Synovial Joint Morphogenesis
por: Shepard, John B., et al.
Publicado: (2007) -
Prognostic significance of Versican expression in gastric adenocarcinoma
por: Shen, X-H, et al.
Publicado: (2015) -
Versican contributes to ligament formation of knee joints
por: Higuchi, Tomoko, et al.
Publicado: (2021)